Clinical Trials Browser

Phase 2/3 × Withdrawn × INDUSTRY × Clear all

NCT07084909 2025-12-10

HARRIER

Phase 2/3 Withdrawn

Carcinoma, Renal Cell, Kidney Neoplasms

NCT06513884 2025-06-22

A Study of HB-202/HB-201 With Pembrolizumab in Patients With HPV16+ Recurrent/Metastatic Oropharyngeal Cancer

Phase 2/3 Withdrawn

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasms, Squamous Cell

NCT04021082 2023-02-21

CELTIC-1: A Phase 2B Study of Cerdulatinib in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL)

Phase 2/3 Withdrawn

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Leukemia, T-Cell, Lymphoma, T-Cell, Peripheral

NCT04037241 2022-04-01

Study of Anti-CEA CAR-T + Chemotherapy VS Chemotherapy Alone in Patients With CEA+Pancreatic Cancer & Liver Metastases

Phase 2/3 Withdrawn

Gastrointestinal

Malignant Tumor of Pancreas Metastatic to Liver

NCT04129320 2022-02-08

Enoblituzumab Plus MGA012 or MGD013 in Squamous Cell Carcinoma of the Head and Neck

Phase 2/3 Withdrawn

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Laryngeal Neoplasms

NCT04083651 2021-05-07

A Study of Methylnaltrexone Bromide (MNTX) in Participants With Advanced Pancreatic Cancer

Phase 2/3 Withdrawn

Gastrointestinal

Pancreatic Neoplasms

NCT01741038 2020-01-22

AlloStim® In-Situ Vaccine in Pre-Treated Metastatic Colorectal Cancer

Phase 2/3 Withdrawn

Gastrointestinal

Colorectal Neoplasms

NCT03165435 2018-05-30

A Study to Evaluate the Efficacy of CV-MG01 (Myasterix) in Myasthenia Gravis

Phase 2/3 Withdrawn

Myasthenia Gravis

NCT02651610 2017-07-11

Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast Cancer

Phase 2/3 Withdrawn

Breast Neoplasms

NCT03070691 2017-05-05

Efficacy, Safety and Tolerability of Topically Applied LDE225 Cream (Hedgehog Pathway Inhibitor) in Adult Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS)

Phase 2/3 Withdrawn

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell

NCT00349518 2016-02-17

Study of Dasatinib in Imatinib Resistant or Intolerant Subjects With Chronic or Advanced Phase CML or Philadelphia Chromosome Positive ALL

Phase 2/3 Withdrawn

LymphoidMyeloidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00735241 2015-05-22

FAST

Phase 2/3 Withdrawn

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT01326078 2014-03-26

Use of Lipid Emulsion or Nanoemulsion of Propofol on Children Undergoing Ambulatory Invasive Procedures.

Phase 2/3 Withdrawn

Other hematologic neoplasm

Leukemia

NCT01452295 2013-12-04

Registry Protocol for Tracking Trial Subjects After VTI-206 Study Completion

Phase 2/3 Withdrawn

Hepatitis, Alcoholic, Liver Failure, Liver Failure, Acute